David Sourdive

Company: Cellectis

Job title: Co-Founder, EVP CMC & Manufacturing

Seminars:

Understanding the Key Considerations to Achieve Large Scale & Commercial Manufacture 12:30 pm

Cellectis’ integrative approach with an industrial manufacturing platform and established end-to-end supply chain – US based large-scale production plant with state-of-the-art technology to manufacture products for clinical development and future commercial use – European based production plant of starting materials (plasmids, RNAs, and vectors) Strategic and technical considerations when manufacturing allogeneic CAR-T therapies: process and…Read more

day: Day One